• Montelukast Aurovitas Spain 4 mg granules EFG

  Form: granules

  Active substance	Dosage
  MONTELUKAST SODIUM	4,16 mg

  ATC: R03D R03DC R03DC03

• Moxifloxacin Aurovitas 400 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  Moxifloxacin Hydrochloride	436,320 mg

  ATC: J01M J01MA J01MA14

• Mycophenolate mofetil Aurovitas 500 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  MYCOPHENOLATE MOFETIL	500 mg

  ATC: L04A L04AA L04AA06

• Mycophenolate mofetil Aurovitas Spain 500 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  MYCOPHENOLATE MOFETIL	500,00 mg

  ATC: L04A L04AA L04AA06

• Naproxen Aurovitas 500 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  NAPROXEN	500 mg

  ATC: M01A M01AE M01AE02

• Naproxen sodium Aurovitas 550 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  SODIUM NAPROXEN	550 mg

  ATC: M01A M01AE M01AE02

• Nebivolol Aurovitas 5 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  NEBIVOLOL HYDROCHLORIDE	5,45 mg

  ATC: C07A C07AB C07AB12

• Neotigason 10 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  ACITRETIN	10 mg

  ATC: D05B D05BB D05BB02

• Neotigason 25 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  ACITRETIN	25 mg

  ATC: D05B D05BB D05BB02

• Nevirapine Aurovitas 400 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  NEVIRAPINE	400 mg

  ATC: J05A J05AG J05AG01

• Olanzapine Aurovitas 10 mg orodispersible tablets EFG

  Form: tablets, buccodispersable

  Active substance	Dosage
  OLANZAPINE	10 mg

  ATC: N05A N05AH N05AH03

• Olanzapine Aurovitas 10 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  OLANZAPINE	10,000 mg

  ATC: N05A N05AH N05AH03

• Olanzapine Aurovitas 15 mg orodispersible tablets EFG

  Form: tablets, buccodispersable

  Active substance	Dosage
  OLANZAPINE	15 mg

  ATC: N05A N05AH N05AH03

• Olanzapine Aurovitas 2.5 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  OLANZAPINE	2,500 mg

  ATC: N05A N05AH N05AH03

• Olanzapine Aurovitas 5 mg orodispersible tablets EFG

  Form: tablets, buccodispersable

  Active substance	Dosage
  OLANZAPINE	5 mg

  ATC: N05A N05AH N05AH03

• Olanzapine Aurovitas 5 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  OLANZAPINE	5,000 mg

  ATC: N05A N05AH N05AH03

• Olanzapine Aurovitas 7.5 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  OLANZAPINE	7,500 mg

  ATC: N05A N05AH N05AH03

• Olmesartan Aurovitas 10 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	10,000 mg

  ATC: C09C C09CA C09CA08

• Olmesartan Aurovitas 20 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	20,000 mg

  ATC: C09C C09CA C09CA08

• Olmesartan Aurovitas 40 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	40,000 mg

  ATC: C09C C09CA C09CA08

• Olmesartan/amlodipine Aurovitas 20 mg/5 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  AMLODIPINE BESYLATE	6,93 mg
  OLMESARTAN MEDOXOMIL	20 mg

  ATC: C09D C09DB C09DB02

• Olmesartan/amlodipine Aurovitas 40 mg/10 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  AMLODIPINE BESYLATE	13,87 mg
  OLMESARTAN MEDOXOMIL	40 mg

  ATC: C09D C09DB C09DB02

• Olmesartan/amlodipine Aurovitas 40 mg/5 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  AMLODIPINE BESYLATE	6,93 mg
  OLMESARTAN MEDOXOMIL	40 mg

  ATC: C09D C09DB C09DB02

• Olmesartan/hydrochlorothiazide Aurovitas 20 mg/12.5 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	20,00 mg
  HYDROCHLOROTHIAZIDE	12,500 mg

  ATC: C09D C09DA C09DA08

• Olmesartan/hydrochlorothiazide Aurovitas 20 mg/25 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	20,00 mg
  HYDROCHLOROTHIAZIDE	25,00 mg

  ATC: C09D C09DA C09DA08

• Olmesartan/hydrochlorothiazide Aurovitas 40 mg/12.5 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  HYDROCHLOROTHIAZIDE	12,500 mg
  OLMESARTAN MEDOXOMIL	40,00 mg

  ATC: C09D C09DA C09DA08

• Olmesartan/hydrochlorothiazide Aurovitas 40 mg/25 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  OLMESARTAN MEDOXOMIL	40,00 mg
  HYDROCHLOROTHIAZIDE	25,000 mg

  ATC: C09D C09DA C09DA08

• Omeprazole Aurovitas Pharma 20 mg gastro-resistant hard capsules EFG

  Form: capsules, hard, enteric-coated

  Active substance	Dosage
  OMEPRAZOLE	20 mg

  ATC: A02B A02BC A02BC01

• Omeprazole Aurovitas Spain 20 mg gastro-resistant hard capsules EFG

  Form: capsules, hard, enteric-coated

  Active substance	Dosage
  OMEPRAZOLE	20,00 mg

  ATC: A02B A02BC A02BC01

• Omeprazole Aurovitas Spain 40 mg gastro-resistant hard capsules

  Form: capsules, hard, enteric-coated

  Active substance	Dosage
  OMEPRAZOLE	40,00 mg

  ATC: A02B A02BC A02BC01

• Orlistat Aurovitas 120 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  ORLISTAT	120 mg

  ATC: A08A A08AB A08AB01

• Pantoprazole Aurovitas 20 mg gastro-resistant tablets EFG

  Form: tablets, enteric-coated

  Active substance	Dosage
  PANTOPRAZOLE SODIUM SESQUIHYDRATE	22,556 mg

  ATC: A02B A02BC A02BC02

• Pantoprazole Aurovitas 40 mg gastro-resistant tablets EFG

  Form: tablets, enteric-coated

  Active substance	Dosage
  PANTOPRAZOLE SODIUM SESQUIHYDRATE	45,112 mg

  ATC: A02B A02BC A02BC02

• Paracetamol Aurovitas 1 g powder for oral solution EFG

  Form: powder for oral solution in sachet

  Active substance	Dosage
  PARACETAMOL	1000 mg

  ATC: N02B N02BE N02BE01

• Paracetamol Aurovitas Spain 1 g tablets EFG

  Form: tablets

  Active substance	Dosage
  PARACETAMOL	1000 mg

  ATC: N02B N02BE N02BE01

• Paracetamol Aurovitas Spain 500 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  PARACETAMOL	500 mg

  ATC: N02B N02BE N02BE01

• Paracetamol Aurovitas Spain 650 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  PARACETAMOL	650 mg

  ATC: N02B N02BE N02BE01

• Paricalcitol Aurovitas Spain 1 microgram soft capsules EFG

  Form: capsules, soft gelatin

  Active substance	Dosage
  PARICALCITOL	0,001 mg

  ATC: H05B H05BX H05BX02

• Paroxetine Aurovitas 20 mg film-coated tablets EFG

  Form: tablets, film-coated

  Active substance	Dosage
  PAROXETINE HYDROCHLORIDE HEMIHYDRATE	22,20 mg

  ATC: N06A N06AB N06AB05

• Paroxetine Aurovitas 30 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  PAROXETINE HYDROCHLORIDE HEMIHYDRATE	33,30 mg

  ATC: N06A N06AB N06AB05

• Perindopril Aurovitas 4 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  PERINDOPRIL ERBUMINE	4 mg

  ATC: C09A C09AA C09AA04

• Pioglitazone Aurovitas 15 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  PIOGLITAZONE HYDROCHLORide	16,535 mg

  ATC: A10B A10BG A10BG03

• Pioglitazone Aurovitas 30 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  PIOGLITAZONE HYDROCHLORide	33,069 mg

  ATC: A10B A10BG A10BG03

• Pirfenidone Aurovitas 267 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  PIRFENIDONE	267 mg

  ATC: L04A L04AX L04AX05

• Pirfenidone Aurovitas 801 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  PIRFENIDONE	801 mg

  ATC: L04A L04AX L04AX05

• Pramipexole Aurovitas 0.18 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  Pramipexole Dihydrochloride Monohydrate	0,250 mg

  ATC: N04B N04BC N04BC05

• Pramipexole Aurovitas 0.7 mg tablets EFG

  Form: tablets

  Active substance	Dosage
  Pramipexole Dihydrochloride Monohydrate	1,000 mg

  ATC: N04B N04BC N04BC05

• Pramipexole Aurovitas Spain 0.26 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  Pramipexole Dihydrochloride Monohydrate	0,375 mg

  ATC: N04B N04BC N04BC05

• Pramipexole Aurovitas Spain 1.05 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  Pramipexole Dihydrochloride Monohydrate	1,5 mg

  ATC: N04B N04BC N04BC05

• Pramipexole Aurovitas Spain 2.1 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  Pramipexole Dihydrochloride Monohydrate	3 mg

  ATC: N04B N04BC N04BC05